Loring Wolcott & Coolidge Fiduciary Advisors LLP Rigel Pharmaceuticals Inc Transaction History

Loring Wolcott & Coolidge Fiduciary Advisors LLP

$10.5 Billion
Q2 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	BUY	$3.09 - $4.54 $83 - $122	27 New	27 $0
Q1 2021 Apr 14, 2021	SELL	$3.35 - $4.93 $90 - $133	-27 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	27	27 $0

Others Institutions Holding RIGL

# of Institutions

116

Shares Held

108M

Call Options Held

556K

Put Options Held

33.9K

Armistice Capital, LLC New York, NY

15.4M
Shares

$165 Million
0.31% of portfolio
Black Rock Inc. New York, NY

14.8M
Shares

$159 Million
0.0% of portfolio
Morgan Stanley New York, NY

14.4M
Shares

$155 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

9.37M
Shares

$101 Million
0.0% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

9.24M
Shares

$99.4 Million
1.12% of portfolio

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $1.86B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.

Account